GEVO Gevo, Inc.

8-K Current Report

Filed: March 5, 2026

Health Care

Industrial Organic Chemicals

Gevo, Inc. (GEVO) 8-K current report filed with SEC EDGAR on March 5, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Full-year 2025 earnings press release issued March 5, 2026 — details in Exhibit 99.1
• Covers fiscal year ended December 31, 2025 — annual results, not a quarterly update

Other Gevo, Inc. 8-K Filings

8-K Mar 16, 2026

Get deeper insights on Gevo, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.